Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Healthcare Realty Trust Inc
Next earnings Jul 29, 2026 · consensus $-0.02 EPS, $285M rev
Last earnings +1.3% on 2026-04-30
Defensive medical-office REIT, but the dividend was cut 15.5%, tenant bankruptcy bites and leasing costs run high — thin coverage.
Healthcare Realty Trust is a medical-office-building REIT whose assets are inherently defensive — healthcare demand is non-cyclical and leases are long (single-tenant buildings average an 11.6-year term). But the company has struggled operationally since the Healthcare Trust of America merger, posting GAAP net losses for three straight years (FY2025 net loss of $246M, an improvement from FY2024's $654M loss). For a REIT those losses are largely non-cash — depreciation & amortization was $564M and impairments recur — so funds from operations, not GAAP EPS, is the right lens. (Note the SEC-tagged 'revenue' line of $28.2M reflects only a narrow contract-revenue item, not rental income, so the headline P/S is not meaningful.)
Sources: SEC EDGAR (CIK 0001360604, latest 10-Q filed 2026-05-01) · EODHD · analysis by claude-code · as of 6/21/2026, 8:56:59 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $10.3M | $13.7M | $17.5M | $19.2M | $28.2M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $66.7M | $40.9M | -$278M | -$654M | -$246M |
| Diluted EPS | $0.45 | $0.15 | -$0.74 | -$1.81 | -$0.71 |
| Net margin | 647.7% | 298.4% | -1594.5% | -3416.4% | -872.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1482 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-05-19 | Bohjalian Thomas N Director | Award | 6.68K @ $20.20 | $135K |
| 2026-05-19 | HENRY DAVID Director | Award | 6.68K @ $20.20 | $135K |
| 2026-05-19 | MOORE CONSTANCE B Director | Award | 6.68K @ $20.20 | $135K |
| 2026-05-19 | RUFRANO GLENN J Director | Award | 6.68K @ $20.20 | $135K |
| 2026-05-19 | WOOD DONALD C Director | Award | 6.68K @ $20.20 | $135K |
| 2026-04-14 | Scott Peter A President and CEO | Tax | 36.0K @ $17.84 | $643K |
| 2026-03-06 | Bohjalian Thomas N Director | Buy | 10.0K @ $18.09 | $181K |
| 2026-03-04 | Gabbay Daniel EVP, Chief Financial Officer | Buy | 10.00 @ $18.74 | $187.40 |